Recent updates on animal models for understanding the etiopathogenesis of polycystic ovarian syndrome

被引:49
|
作者
Corrie, Leander [1 ]
Gulati, Monica [1 ]
Singh, Sachin Kumar [1 ]
Kapoor, Bhupinder [1 ]
Khursheed, Rubiya [1 ]
Awasthi, Ankit [1 ]
Vishwas, Sukriti [1 ]
Chellappan, Dinesh Kumar [2 ]
Gupta, Gaurav [3 ]
Jha, Niraj Kumar [4 ]
Anand, Krishnan [5 ]
Dua, Kamal [6 ]
机构
[1] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara 144411, Punjab, India
[2] Int Med Univ, Sch Pharm, Dept Life Sci, Kuala Lumpur 57000, Malaysia
[3] Suresh Gyan Vihar Univ, Sch Pharm, Mahal Rd, Jaipur, Rajasthan, India
[4] Sharda Univ, Sch Engn & Technol SET, Dept Biotechnol, Greater Noida 201310, Uttar Pradesh, India
[5] Univ Free State, Fac Hlth Sci, Sch Pathol, Dept Chem Pathol,Natl Hlth Lab Serv, Bloemfontein, South Africa
[6] Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Ultimo, Australia
关键词
Polycystic ovarian syndrome; Luteinizing hormone; Dehydroepiandrosterone model; Dihydrotestosterone model; Letrozole; SEX STEROID-RECEPTORS; ESTRADIOL VALERATE; RAT MODEL; INSULIN-RESISTANCE; FOLLICULAR DEVELOPMENT; LUTEINIZING-HORMONE; SIGNALING PATHWAY; OXIDATIVE STRESS; GENE-EXPRESSION; CYSTIC OVARIES;
D O I
10.1016/j.lfs.2021.119753
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Polycystic ovarian syndrome (PCOS) is the primary cause of female infertility affecting several women worldwide. Changes in hormonal functions such as hyperandrogenism are considered a significant factor in developing PCOS in women. In addition, many molecular pathways are involved in the pathogenesis of PCOS in women. To have better insights about PCOS, it is data from clinical studies carried on women suffering from PCOS should be collected. However, this approach has several implications, including ethical considerations, cost involved and availability of subject. Moreover, during the early drug development process, it is always advisable to use nonhuman models mimicking human physiology as they are less expensive, readily available, have a shorter gestation period and less risk involved. Many animal models have been reported that resemble the PCOS pathways in human subjects. However, the models developed on rats and mice are more preferred over other rodent/non-rodent models due to their closer resemblance with human PCOS development mechanism. The most extensively reported PCOS models for rats and mice include those induced by using testosterone, letrozole and estradiol valerate. As the pathophysiology of PCOS is complex, none of the explored models completely surrogates the PCOS related conditions occurring in women. Hence, there is a need to develop an animal model that can resemble the pathophysiology of PCOS in women. The review focuses on various animal models explored to understand the pathophysiology of PCOS. The article also highlights some environmental and food-related models that have been used to induce PCOS.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Animal Models in Polycystic Ovarian Syndrome
    Dunn, Ariel J.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2021, 64 (01): : 126 - 133
  • [2] Animal Models for the Study of Polycystic Ovarian Syndrome
    Oakley, Oliver
    Lin, Po-Ching
    Bridges, Phillip
    Ko, CheMyong
    ENDOCRINOLOGY AND METABOLISM, 2011, 26 (03) : 193 - 202
  • [3] Understanding Polycystic Ovarian Syndrome
    Edmondson, Emily S.
    PHYSICIAN ASSISTANT CLINICS, 2018, 3 (03) : 353 - +
  • [4] Experimental Animal Models Experiment Used to Develop Polycystic Ovarian Syndrome
    Tokmak, Aytekin
    Ersak, Duygu Tugrul
    Sahin, Ayse
    MEDICAL JOURNAL OF BAKIRKOY, 2019, 15 (04) : 333 - 338
  • [5] POLYCYSTIC OVARIAN DISEASE - ANIMAL-MODELS
    MAHAJAN, DK
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1988, 17 (04) : 705 - 732
  • [6] The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer
    Khalil, I.
    Brewer, M. A.
    Neyarapally, T.
    Runowicz, C. D.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (02) : 282 - 285
  • [7] Animal models of the polycystic ovary syndrome phenotype
    Padmanabhan, Vasantha
    Veiga-Lopez, Almudena
    STEROIDS, 2013, 78 (08) : 734 - 740
  • [8] Update on Animal Models of Polycystic Ovary Syndrome
    Stener-Victorin, Elisabet
    ENDOCRINOLOGY, 2022, 163 (12)
  • [9] Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review
    Paixao, Larissa
    Ramos, Ramon B.
    Lavarda, Anita
    Morsh, Debora M.
    Spritzer, Poli Mara
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2017, 15
  • [10] Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review
    Larissa Paixão
    Ramon B. Ramos
    Anita Lavarda
    Debora M. Morsh
    Poli Mara Spritzer
    Reproductive Biology and Endocrinology, 15